tiprankstipranks
Advertisement
Advertisement
Cardiol Therapeutics’ CardiolRx featured in Phase 2 pericarditis published trial
PremiumThe FlyCardiol Therapeutics’ CardiolRx featured in Phase 2 pericarditis published trial
1M ago
Cardiol Therapeutics to Highlight CardiolRx Programs at B. Riley Mind, Muscle & Vision Summit
Premium
Company Announcements
Cardiol Therapeutics to Highlight CardiolRx Programs at B. Riley Mind, Muscle & Vision Summit
1M ago
Cardiol Therapeutics Shareholders Back Board Slate and Auditor at 2026 AGM
Premium
Company Announcements
Cardiol Therapeutics Shareholders Back Board Slate and Auditor at 2026 AGM
2M ago
Cardiol Therapeutics’ Phase II MAvERIC Pericarditis Data Accepted by JAHA as Phase III Trial Nears Completion
PremiumCompany AnnouncementsCardiol Therapeutics’ Phase II MAvERIC Pericarditis Data Accepted by JAHA as Phase III Trial Nears Completion
3M ago
Cardiol Therapeutics expands U.S. MAVERIC Phase III trial network
Premium
The Fly
Cardiol Therapeutics expands U.S. MAVERIC Phase III trial network
4M ago
Cardiol Therapeutics Expands U.S. Phase III MAVERIC Trial Network as Enrollment Reaches 75%
Premium
Company Announcements
Cardiol Therapeutics Expands U.S. Phase III MAVERIC Trial Network as Enrollment Reaches 75%
4M ago
Cardiol Therapeutics to Present Cardiovascular Pipeline Update at TD Cowen Health Care Conference
PremiumCompany AnnouncementsCardiol Therapeutics to Present Cardiovascular Pipeline Update at TD Cowen Health Care Conference
6M ago
Cardiol Therapeutics’ ARCHER Phase II Myocarditis Data Published in ESC Heart Failure
Premium
Company Announcements
Cardiol Therapeutics’ ARCHER Phase II Myocarditis Data Published in ESC Heart Failure
6M ago
Cardiol Therapeutics Secures $14.85 Million Bought-Deal Unit Financing
Premium
Company Announcements
Cardiol Therapeutics Secures $14.85 Million Bought-Deal Unit Financing
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100